Solid Biosciences Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Solid Biosciences Inc.
RECRUITINGPhase 3NCT07160634
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
This is a Phase 3, double-blind, placebo-controlled study with the primary objective of evaluating the efficacy of a single IV infusion of SGT-003 in pediatric ambulant male...
Sponsor: Solid Biosciences Inc.Enrolling: 802 locations
Duchenne Muscular Dystrophy
RECRUITINGPhase 1 / Phase 2NCT06138639
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
This is a multicenter, open-label, non-randomized study to investigate the safety, tolerability, and efficacy of a single intravenous (IV) infusion of SGT-003 in participants with...
Sponsor: Solid Biosciences Inc.Enrolling: 6015 locations
Duchenne Muscular Dystrophy